There is a lot in this news.
= Evolis exceeding expectations to this point in time. The risk ATM maybe having enough stock to keep the shelves stocked . Oh dear . Stay tuned the Company says.
= HU91 funding partnership(s) "commenced discussions with corporate venture groups with the view to seek a strategic,
non-dilutive investment into this potentially highly
lucrative program." Suggests that the partner(s) will buy a stake in the program rather than the company. $500m banchmark valuation would be reduced by any
partnership arrangement. Given CDY's current market cap and resources OK, I agree with the strategy.
= Preclinical MK antibody testing are a must read. Derisks the science for several pipelines.
= Some nice new collaborations mentioned. Did I read Pfizer amongst them. Early days maybe but an excellent conference result!
Plenty of cash and more at the sidelines it seems. Read in context with the Boardroom Radio R&D rebate chat, and the response to the ASX I remain very very happy.
cheers
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid News
Ann: Cellmid News , page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $7.343K | 917.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 539388 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 340000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 539388 | 0.008 |
2 | 1111500 | 0.007 |
4 | 606527 | 0.006 |
1 | 300000 | 0.005 |
2 | 525000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 340000 | 1 |
0.010 | 157763 | 1 |
0.011 | 100000 | 1 |
0.012 | 100000 | 1 |
0.013 | 750000 | 1 |
Last trade - 12.51pm 17/07/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |